… infective endocarditis, compared to 16.7% of the patients in … Staphylococcus aureus was
found in 38.9%, non--haemolytic … The incidence of infective endocarditis increased during the …

… clinical features and outcomes in patients with Staphylococcus aureus (SA) infective endocarditis
… One major finding of our study was that we found a significant difference in the clinical …

… There is a high incidence of infective endocarditis (IE) in Staphylococcus aureus
bacteraemia (SAB) (29 %) and a large percentage of cases are not evident on clinical grounds. …

… valve endocarditis and 82 of prosthetic valve endocarditis. Staphylococcus aureus was the
… Multivariate analysis revealed the following clinical factors in patients with native valve IE as …

… -resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) is increasing. This
study compared clinical characteristics and mortality in patients with methicillin-sensitive S. …

… Staphylococcus aureus is the second leading cause of bacteremia and the leading cause of
infective endocarditis … Medical advances, such as intravascular and prosthetic devices and …

… Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, …

… Bacterial preparation Clinical IE isolates of Staphylococcus aureus were derived from the
sample collection of the Partial Oral antibiotic Endocarditis Treatment …

… Infective endocarditis (IE) is a life-threatening infection of the heart endothelium and valves.
Staphylococcus aureus is a predominant cause of severe IE and is frequently associated …

… Entry diagnoses were determined according to the modified Duke criteria for infective
endocarditis [16]. Final diagnoses were based on standard clinical definitions as outlined in the …